Brown Advisory
IMCR icon

Brown Advisory’s Immunocore IMCR Stock Holding History

Brown Advisory’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,000
Closed -$240K – 1210
2023
Q2 		$240K Buy
+4,000
New +$228K ﹤0.01% 1073
2023
Q1 		– Sell
-4,000
Closed -$228K – 1240
2022
Q4 		$228K Buy
+4,000
New +$225K ﹤0.01% 1095

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Brown Advisory's IMCR Position: Q3 2023 in Review

Brown Advisory sold out of Immunocore (IMCR) in Q3 2023, closing a stake of 4,000 shares — an estimated $240K sold.

Brown Advisory first reported a position in IMCR in Q4 2022 and held it in 2 quarters. The position peaked at $240K in Q2 2023. 125 funds tracked by Wall St. Rank hold IMCR as of Q3 2023.

  • Brown Advisory reported no remaining Immunocore position as of Q3 2023 after selling out during the quarter.
  • Brown Advisory sold 4,000 Immunocore shares in Q3 2023, an estimated $240K.
  • Brown Advisory first reported a position in Immunocore in Q4 2022 and held it in 2 quarters.
  • Brown Advisory's Immunocore position peaked at $240K in Q2 2023.
  • 125 funds tracked by Wall St. Rank held Immunocore as of Q3 2023.

Based on Brown Advisory's 13F filing for Q3 2023, filed 25 Oct 2023.